An atypical immunophenotype in generalized eruptive histiocytosis: a case report of coexisting scattered S-100 positivity and seropositivity for Anti-nRNP/Sm antibodies - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Uncommon Immunophenotypic Features in Generalized Eruptive Histiocytosis: A Case Study Highlighting Scattered S-100 Positivity and Anti-nRNP/Sm Antibody Seropositivity

  • By

  • Xinran Du

  • Siyu Pu

  • Ruizheng Zhu

  • Dongjie Guo

  • August 18, 2026

Share

Clinical Scorecard: Uncommon Immunophenotypic Features in Generalized Eruptive Histiocytosis: A Case Study Highlighting Scattered S-100 Positivity and Anti-nRNP/Sm Antibody Seropositivity

At a Glance

CategoryDetail
ConditionGeneralized Eruptive Histiocytosis (GEH)
Key MechanismsInfiltration of histiocytes, plasma cells, and eosinophils in the dermis; atypical immunophenotype with S-100 positivity and anti-nRNP/Sm antibodies.
Target PopulationAdults aged 30 to 60 years.
Care SettingDermatology and pathology evaluation.

Key Highlights

  • GEH is characterized by multiple symmetrical papular lesions.
  • Atypical case presented with scattered S-100 positivity and anti-nRNP/Sm antibody seropositivity.
  • Histopathological findings include dense infiltrates of histiocytes and lymphoplasmacytic cells.
  • S-100 positivity is non-specific and should be interpreted with clinical context.
  • Anti-nRNP/Sm antibodies are associated with systemic autoimmune conditions.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of GEH should be based on clinical presentation and histopathological characteristics.

Management

  • Topical neomycin ointment was applied to the biopsy wound; other lesions received no treatment.

Monitoring & Follow-up

  • Patient monitored via telephone follow-up for 19 months with no new symptoms reported.

Risks

  • Presence of anti-nRNP/Sm antibodies may indicate potential systemic autoimmune conditions.

Patient & Prescribing Data

Adult male, 60 years old.

Stable condition noted at follow-up; no new clinical assessments conducted.

Clinical Best Practices

  • Evaluate S-100 positivity in conjunction with overall clinicopathological features.
  • Consider longitudinal follow-up for accurate diagnosis of autoimmune conditions.

Related Resources & Content

    Original Source(s)

    Related Content